FI950515L - Isoseriinijohdannaiset ja niiden käyttö leukotrieeniantagonisteina - Google Patents
Isoseriinijohdannaiset ja niiden käyttö leukotrieeniantagonisteina Download PDFInfo
- Publication number
- FI950515L FI950515L FI950515A FI950515A FI950515L FI 950515 L FI950515 L FI 950515L FI 950515 A FI950515 A FI 950515A FI 950515 A FI950515 A FI 950515A FI 950515 L FI950515 L FI 950515L
- Authority
- FI
- Finland
- Prior art keywords
- leukotriene antagonists
- isoserine derivatives
- isoserine
- derivatives
- leukotriene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Control Of Transmission Device (AREA)
- Control Of Driving Devices And Active Controlling Of Vehicle (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929216768A GB9216768D0 (en) | 1992-08-07 | 1992-08-07 | Chemical compounds |
| PCT/DK1993/000254 WO1994003431A1 (en) | 1992-08-07 | 1993-08-05 | Isoserine derivatives and their use as leukotriene antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI950515A7 FI950515A7 (fi) | 1995-02-06 |
| FI950515L true FI950515L (fi) | 1995-02-06 |
| FI950515A0 FI950515A0 (fi) | 1995-02-06 |
Family
ID=10719973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI950515A FI950515A0 (fi) | 1992-08-07 | 1993-08-05 | Isoseriinijohdannaiset ja niiden käyttö leukotrieeniantagonisteina |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5576438A (es) |
| EP (1) | EP0654026B1 (es) |
| JP (1) | JPH08504749A (es) |
| KR (1) | KR950701319A (es) |
| AT (1) | ATE149030T1 (es) |
| AU (1) | AU666967B2 (es) |
| CA (1) | CA2134565A1 (es) |
| DE (1) | DE69308212T2 (es) |
| DK (1) | DK0654026T3 (es) |
| ES (1) | ES2100550T3 (es) |
| FI (1) | FI950515A0 (es) |
| GB (1) | GB9216768D0 (es) |
| GR (1) | GR3023069T3 (es) |
| NZ (1) | NZ254741A (es) |
| RU (1) | RU2126389C1 (es) |
| WO (1) | WO1994003431A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9414590D0 (en) * | 1994-07-20 | 1994-09-07 | Leo Pharm Prod Ltd | Chemical compounds |
| GB9524185D0 (en) * | 1995-11-27 | 1996-01-31 | Leo Pharm Prod Ltd | Substituted diols |
| FR2751969B1 (fr) * | 1996-08-01 | 1998-12-04 | Centre Nat Rech Scient | Composes activateurs du canal cftr, et compositions pharmaceutiques les contenant |
| KR20000044978A (ko) * | 1998-12-30 | 2000-07-15 | 성재갑 | 각질 박리 촉진용 조성물 |
| CN103044277B (zh) * | 2013-01-07 | 2015-04-08 | 华东师范大学 | 光学纯α-羟基-β-氨基丙酸酯衍生物的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4962203A (en) * | 1985-06-18 | 1990-10-09 | Merck Frost Canada, Inc. | 2-substituted quinolines useful as leukotriene antagonists |
| IE861607L (en) * | 1985-06-18 | 1986-12-18 | Bunce Roger A | 2-substituted quinolines |
| US4918081A (en) * | 1988-06-20 | 1990-04-17 | Rorer Pharmaceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene d4 |
| US5102881A (en) * | 1988-06-27 | 1992-04-07 | Merck Frosst Canada, Inc. | Quinoline ether alkanoic acids |
| GB8919504D0 (en) * | 1989-08-29 | 1989-10-11 | Leo Pharm Prod Ltd | Chemical compounds |
| IE920499A1 (en) * | 1991-02-21 | 1992-08-26 | Merck Frosst Canada Inc | Quinoline-containing ketoacids as leukotriene antagonists |
| US5270324A (en) * | 1992-04-10 | 1993-12-14 | Merck Frosst Canada, Inc. | Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists |
-
1992
- 1992-08-07 GB GB929216768A patent/GB9216768D0/en active Pending
-
1993
- 1993-08-05 DK DK93917564.2T patent/DK0654026T3/da active
- 1993-08-05 NZ NZ254741A patent/NZ254741A/en unknown
- 1993-08-05 KR KR1019940703906A patent/KR950701319A/ko active Pending
- 1993-08-05 US US08/335,860 patent/US5576438A/en not_active Expired - Fee Related
- 1993-08-05 ES ES93917564T patent/ES2100550T3/es not_active Expired - Lifetime
- 1993-08-05 AU AU46982/93A patent/AU666967B2/en not_active Ceased
- 1993-08-05 RU RU94046453A patent/RU2126389C1/ru active
- 1993-08-05 FI FI950515A patent/FI950515A0/fi unknown
- 1993-08-05 WO PCT/DK1993/000254 patent/WO1994003431A1/en not_active Ceased
- 1993-08-05 EP EP93917564A patent/EP0654026B1/en not_active Expired - Lifetime
- 1993-08-05 JP JP6504910A patent/JPH08504749A/ja active Pending
- 1993-08-05 CA CA002134565A patent/CA2134565A1/en not_active Abandoned
- 1993-08-05 DE DE69308212T patent/DE69308212T2/de not_active Expired - Fee Related
- 1993-08-05 AT AT93917564T patent/ATE149030T1/de not_active IP Right Cessation
-
1997
- 1997-04-08 GR GR970400737T patent/GR3023069T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2134565A1 (en) | 1994-02-17 |
| FI950515A7 (fi) | 1995-02-06 |
| RU94046453A (ru) | 1996-09-27 |
| EP0654026B1 (en) | 1997-02-19 |
| GB9216768D0 (en) | 1992-09-23 |
| AU666967B2 (en) | 1996-02-29 |
| WO1994003431A1 (en) | 1994-02-17 |
| RU2126389C1 (ru) | 1999-02-20 |
| NZ254741A (en) | 1997-07-27 |
| DK0654026T3 (da) | 1997-07-14 |
| JPH08504749A (ja) | 1996-05-21 |
| DE69308212D1 (de) | 1997-03-27 |
| EP0654026A1 (en) | 1995-05-24 |
| GR3023069T3 (en) | 1997-07-30 |
| DE69308212T2 (de) | 1997-09-18 |
| US5576438A (en) | 1996-11-19 |
| ES2100550T3 (es) | 1997-06-16 |
| KR950701319A (ko) | 1995-03-23 |
| AU4698293A (en) | 1994-03-03 |
| FI950515A0 (fi) | 1995-02-06 |
| ATE149030T1 (de) | 1997-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI944734L (fi) | Kinoliinijohdannaiset leukotrieeniantagonisteina | |
| FI953666A7 (fi) | Hetersykliset yhdisteet ja niiden valmistus ja käyttö | |
| FI945625L (fi) | Indolokarbatsoli-imidit ja niiden käyttö | |
| FI952179A7 (fi) | Uusia 3,3-difenyylipropyyliamiineja, niiden käyttö ja valmistus | |
| FI954131L (fi) | Heterosykliset yhdisteet ja niiden valmistus ja käyttö | |
| FI930747A7 (fi) | Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö | |
| FI931901A7 (fi) | Atsoliyhdisteet, niiden valmistus ja käyttö | |
| FI943421L (fi) | 1,5-bentsodiatsepiinijohdannaiset ja niiden käyttö lääkkeenä | |
| FI955051A0 (fi) | Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö | |
| FI935887A7 (fi) | Tiatzolidiinidionijohdannaiset, niiden valmistus ja käyttö | |
| FI954130A7 (fi) | Heterosykliset yhdisteet ja niiden valmistus ja käyttö | |
| FI934426A7 (fi) | Tiatsolidiinidionijohdokset, niiden valmistus ja käyttö | |
| FI962043L (fi) | Substituoidut 5-rengas-heterosyklit, niiden valmistus ja niiden käyttö | |
| FI943313L (fi) | Heterosykliset yhdisteet ja niiden valmistus ja käyttö | |
| FI930746A7 (fi) | Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö | |
| FI943473L (fi) | Bentsopyraani ja senkaltaiset LTB4-antagonistit | |
| FI935728A7 (fi) | Substituoituja 4-fenyylipyridoneja ja 4-fenyyli-2-alkoksipyridiinejä | |
| FI943474L (fi) | Bentsopyraani ja senkaltaiset LTB4-antagonistit | |
| FI910728A7 (fi) | Leukotrieeni-antagonisteja koskevia ja niihin liittyviä parannuksia | |
| FI953021A7 (fi) | 4-bentsoyyli-isoksatsolin johdannaisia ja niiden käyttö herbisideinä | |
| FI952458L (fi) | Dimetyylibentsofuraanien ja dimetyylibentsopyraanien käyttö 5-HT3-antagonisteina | |
| FI930716A7 (fi) | Uusia aryylikarbonyyliaminoalkyylidihydro-oksopyridiinejä, niiden valmistus ja käyttö | |
| FI923475A7 (fi) | Substituoidut ureayhdisteet ja niiden valmistus ja käyttö | |
| FI941958A7 (fi) | 2-heterosyklinenetyyliamiinijohdannaiset ja niiden käyttö lääkkeinä | |
| FI923458A7 (fi) | 4,5-sykloalkano-3-bentsatsepin-7-olijohdannaiset ja niiden käyttö |